Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasutaka Sadaga
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institution:
Tokyo Metropolitan Komagome Hospital
ORCID:
0009-0000-7669-5871
Observed ORCID:
0009-0000-7669-5871
OpenAlex ID:
A5093021327
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience
2025
·
Yusuke Uchibori
, Shuhei Kurosawa
, et al.
·
Frontiers in Immunology
·
12
PDF
Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Kazuya Kurihara
, Daichi Sadato
, et al.
·
Transplantation and Cellular Therapy
·
8
Real‐World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients
2025
·
Yasutaka Masuda
, Takashi Toya
, et al.
·
Transplant Infectious Disease
·
7
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center
2025
·
Shuhei Kurosawa
, Kairi Kojo
, et al.
·
Bone Marrow Transplantation
·
7
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults
2025
·
Kaori Kondo
, Yuho Najima
, et al.
·
Leukemia Research
·
4
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia
2024
·
Fumihiko Ouchi
, Naoki Shingai
, et al.
·
International Journal of Hematology
·
4
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era
2026
·
Atsushi Jinguji
, Shuhei Kurosawa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation
2025
·
Yasutaka Sadaga
, Yuho Najima
, et al.
·
Transplantation and Cellular Therapy
·
3
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study
2025
·
Shuhei Kurosawa
, Kana Kato
, et al.
·
Japanese Journal of Thrombosis and Hemostasis
·
3
PDF
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation
2023
·
Naoki Shingai
, Akihito Ota
, et al.
·
Transplantation and Cellular Therapy
·
3
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation
2025
·
Yasutaka Sadaga
, Daisuke Watanabe
, et al.
·
Hematology
·
2
Drug‐induced liver injury due to granulocyte colony‐stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation
2025
·
Kana Kato
, Shuhei Kurosawa
, et al.
·
Vox Sanguinis
·
1
A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation
2023
·
Yasutaka Sadaga
, Yuho Najima
, et al.
·
Blood
·
1
PDF
Clonal hematopoiesis in long-term survivors after allogeneic hematopoietic cell transplantation: associations with active chronic graft-versus-host disease, donor age, and transplantation for chronic myeloid leukemia
2026
·
Takashi Toya
, Daichi Sadato
, et al.
·
Haematologica
PDF
Clinical impact of infused CD3-positive cell dose in unrelated peripheral blood stem cell transplantation
2026
·
Yasutaka Sadaga
, Shuhei Kurosawa
, et al.
·
International Journal of Hematology
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis].
2026
·
Kairi Kojo
, Yuho Najima
, et al.
·
PubMed
TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT
2025
·
Kairi Kojo
, Hiroaki Shimizu
, et al.
·
Blood
PDF
Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis
2025
·
Yasutaka Sadaga
, Yuho Najima
, et al.
·
Blood
PDF
[Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease].
2025
·
Kana Kato
, Takeshi Kobayashi
, et al.
·
PubMed
[Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis].
2025
·
Fumihiko Ouchi
, Yuho Najima
, et al.
·
PubMed
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse].
2024
·
Kazuya Kurihara
, Daichi Sadato
, et al.
·
PubMed
[Ruptured mycotic cerebral aneurysm in an adult T-cell leukemia/lymphoma patient undergoing allogeneic stem cell transplantation].
2024
·
Satoshi Koi
, Hiroaki Shimizu
, et al.
·
PubMed
Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
2023
·
Chika Kato
, Yuho Najima
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
23
Citation count:
58
H-index:
4
I10-index:
1
Year
Topic
Type